{"trigger": ["<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> Activates <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> Signaling and Deregulates the <extra_id_0> Rb <extra_id_2> Protein <extra_id_1> Cell Cycle Pathway", "LMP1 Activates Akt Signaling and Deregulates the Rb Cell Cycle Pathway"], "relation": []}
{"trigger": ["<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transformation of rodent fibroblasts requires activation of PI3K and <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> [ 5 ] .", "LMP1 transformation of rodent fibroblasts <extra_id_0> requires <extra_id_2> Positive_regulation <extra_id_1> <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of PI3K and Akt [ 5 ] ."], "relation": [["LMP1 transformation of rodent fibroblasts <extra_id_0> requires <extra_id_2> Positive_regulation <extra_id_1> activation of PI3K and Akt [ 5 ] .", "LMP1 transformation of rodent fibroblasts requires <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> of PI3K and Akt [ 5 ] ."], ["LMP1 transformation of rodent fibroblasts requires <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of PI3K and Akt [ 5 ] .", "LMP1 transformation of rodent fibroblasts requires activation of PI3K and <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> [ 5 ] ."]]}
{"trigger": ["Additionally , activated <extra_id_0> pAkt <extra_id_2> Protein <extra_id_1> is frequently detected in NPC and the neoplastic Reed-Sternberg cells of classical HD [ 39 , 40 ] .", "Additionally , <extra_id_0> activated <extra_id_2> Positive_regulation <extra_id_1> pAkt is frequently detected in NPC and the neoplastic Reed-Sternberg cells of classical HD [ 39 , 40 ] ."], "relation": [["Additionally , <extra_id_0> activated <extra_id_2> Positive_regulation <extra_id_1> pAkt is frequently detected in NPC and the neoplastic Reed-Sternberg cells of classical HD [ 39 , 40 ] .", "Additionally , activated <extra_id_0> pAkt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> is frequently detected in NPC and the neoplastic Reed-Sternberg cells of classical HD [ 39 , 40 ] ."]]}
{"trigger": ["To determine if <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> signaling is activated in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic mice , <extra_id_0> pAkt <extra_id_2> Protein <extra_id_1> and several of its targets were assessed by immunoblotting of splenic <extra_id_0> CD19 <extra_id_2> Protein <extra_id_1> + MACS-purified B cells .", "To determine if Akt signaling is activated in LMP1 transgenic mice , pAkt and several of its targets were assessed by immunoblotting of splenic CD19 + MACS-purified B cells ."], "relation": []}
{"trigger": ["<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic B cells had increased levels of <extra_id_0> pAkt <extra_id_2> Protein <extra_id_1> compared to wild-type lymphocytes ; however , progression to lymphoma in both <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> - positive and - negative lymphoma cells did not further increase <extra_id_0> pAkt <extra_id_2> Protein <extra_id_1> levels .", "LMP1 transgenic B cells had <extra_id_0> increased <extra_id_2> Positive_regulation <extra_id_1> levels of pAkt compared to wild-type lymphocytes ; however , progression to lymphoma in both LMP1 - positive and - negative lymphoma cells did not further <extra_id_0> increase <extra_id_2> Positive_regulation <extra_id_1> pAkt levels ."], "relation": [["LMP1 transgenic B cells had <extra_id_0> increased <extra_id_2> Positive_regulation <extra_id_1> levels of pAkt compared to wild-type lymphocytes ; however , progression to lymphoma in both LMP1 - positive and - negative lymphoma cells did not further increase pAkt levels .", "LMP1 transgenic B cells had increased levels of <extra_id_0> pAkt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> compared to wild-type lymphocytes ; however , progression to lymphoma in both LMP1 - positive and - negative lymphoma cells did not further increase pAkt levels ."], ["LMP1 transgenic B cells had increased levels of pAkt compared to wild-type lymphocytes ; however , progression to lymphoma in both LMP1 - positive and - negative lymphoma cells did not further <extra_id_0> increase <extra_id_2> Positive_regulation <extra_id_1> pAkt levels .", "LMP1 transgenic B cells had increased levels of pAkt compared to wild-type lymphocytes ; however , progression to lymphoma in both LMP1 - positive and - negative lymphoma cells did not further increase <extra_id_0> pAkt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> levels ."]]}
{"trigger": ["The <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> target <extra_id_0> glycogen synthase kinase 3 <extra_id_2> Protein <extra_id_1> ( <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_1> ) is inactivated by phosphorylation ; however , increased phosphorylated <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_1> was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples ( Figure 6A ) .", "The Akt <extra_id_0> target <extra_id_2> Binding <extra_id_1> glycogen synthase kinase 3 ( GSK3 ) is <extra_id_0> inactivated <extra_id_2> Negative_regulation <extra_id_1> by phosphorylation ; however , <extra_id_0> increased <extra_id_2> Positive_regulation <extra_id_1> <extra_id_0> phosphorylated <extra_id_2> Phosphorylation <extra_id_1> GSK3 was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples ( Figure 6A ) ."], "relation": [["The Akt <extra_id_0> target <extra_id_2> Binding <extra_id_1> glycogen synthase kinase 3 ( GSK3 ) is inactivated by phosphorylation ; however , increased phosphorylated GSK3 was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples ( Figure 6A ) .", "The <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> target <extra_id_0> glycogen synthase kinase 3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> ( GSK3 ) is inactivated by phosphorylation ; however , increased phosphorylated GSK3 was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples ( Figure 6A ) ."], ["The Akt target glycogen synthase kinase 3 ( GSK3 ) is <extra_id_0> inactivated <extra_id_2> Negative_regulation <extra_id_1> by phosphorylation ; however , increased phosphorylated GSK3 was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples ( Figure 6A ) .", "The Akt <extra_id_0> target <extra_id_2> Binding <extra_id_2> Theme <extra_id_1> glycogen synthase kinase 3 ( GSK3 ) is inactivated by phosphorylation ; however , increased phosphorylated GSK3 was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples ( Figure 6A ) ."], ["The Akt target glycogen synthase kinase 3 ( GSK3 ) is inactivated by phosphorylation ; however , <extra_id_0> increased <extra_id_2> Positive_regulation <extra_id_1> phosphorylated GSK3 was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples ( Figure 6A ) .", "The Akt target glycogen synthase kinase 3 ( GSK3 ) is inactivated by phosphorylation ; however , increased <extra_id_0> phosphorylated <extra_id_2> Phosphorylation <extra_id_2> Theme <extra_id_1> GSK3 was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples ( Figure 6A ) ."], ["The Akt target glycogen synthase kinase 3 ( GSK3 ) is inactivated by phosphorylation ; however , increased <extra_id_0> phosphorylated <extra_id_2> Phosphorylation <extra_id_1> GSK3 was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples ( Figure 6A ) .", "The Akt target glycogen synthase kinase 3 ( GSK3 ) is inactivated by phosphorylation ; however , increased phosphorylated <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples ( Figure 6A ) ."]]}
{"trigger": ["This finding indicates that <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_1> is not a target of activated <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> in the <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells .", "This finding indicates that GSK3 is not a <extra_id_0> target <extra_id_2> Binding <extra_id_1> of <extra_id_0> activated <extra_id_2> Positive_regulation <extra_id_1> Akt in the LMP1 transgenic lymphocytes and lymphoma cells ."], "relation": [["This finding indicates that GSK3 is not a <extra_id_0> target <extra_id_2> Binding <extra_id_1> of activated Akt in the LMP1 transgenic lymphocytes and lymphoma cells .", "This finding indicates that <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> is not a target of activated <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> in the LMP1 transgenic lymphocytes and lymphoma cells ."], ["This finding indicates that GSK3 is not a target of <extra_id_0> activated <extra_id_2> Positive_regulation <extra_id_1> Akt in the LMP1 transgenic lymphocytes and lymphoma cells .", "This finding indicates that GSK3 is not a target of activated <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> in the LMP1 transgenic lymphocytes and lymphoma cells ."]]}
{"trigger": ["Similarly , activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> without phosphorylation of <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_1> has been previously shown in EBV - positive HD [ 40 ] .", "Similarly , <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of Akt without <extra_id_0> phosphorylation <extra_id_2> Phosphorylation <extra_id_1> of GSK3 has been previously shown in EBV - positive HD [ 40 ] ."], "relation": [["Similarly , <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of Akt without phosphorylation of GSK3 has been previously shown in EBV - positive HD [ 40 ] .", "Similarly , activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> without phosphorylation of GSK3 has been previously shown in EBV - positive HD [ 40 ] ."], ["Similarly , activation of Akt without <extra_id_0> phosphorylation <extra_id_2> Phosphorylation <extra_id_1> of GSK3 has been previously shown in EBV - positive HD [ 40 ] .", "Similarly , activation of Akt without phosphorylation of <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> has been previously shown in EBV - positive HD [ 40 ] ."]]}
{"trigger": ["In contrast , the wild-type lymphocytes lacked activated <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> but did have detectable phosphorylated <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_1> .", "In contrast , the wild-type lymphocytes lacked <extra_id_0> activated <extra_id_2> Positive_regulation <extra_id_1> Akt but did have detectable <extra_id_0> phosphorylated <extra_id_2> Phosphorylation <extra_id_1> GSK3 ."], "relation": [["In contrast , the wild-type lymphocytes lacked <extra_id_0> activated <extra_id_2> Positive_regulation <extra_id_1> Akt but did have detectable phosphorylated GSK3 .", "In contrast , the wild-type lymphocytes lacked activated <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> but did have detectable phosphorylated GSK3 ."], ["In contrast , the wild-type lymphocytes lacked activated Akt but did have detectable <extra_id_0> phosphorylated <extra_id_2> Phosphorylation <extra_id_1> GSK3 .", "In contrast , the wild-type lymphocytes lacked activated Akt but did have detectable phosphorylated <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> ."]]}
{"trigger": ["This further suggests that additional pathways are involved in the regulation of <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_1> .", "This further suggests that additional pathways are involved in the <extra_id_0> regulation <extra_id_2> Regulation <extra_id_1> of GSK3 ."], "relation": [["This further suggests that additional pathways are involved in the <extra_id_0> regulation <extra_id_2> Regulation <extra_id_1> of GSK3 .", "This further suggests that additional pathways are involved in the regulation of <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> ."]]}
{"trigger": ["To identify other potential <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> targets , immunoblot analysis for <extra_id_0> p-mTOR <extra_id_2> Protein <extra_id_1> was performed .", "To identify other potential Akt <extra_id_0> targets <extra_id_2> Binding <extra_id_1> , immunoblot analysis for p-mTOR was performed ."], "relation": [["To identify other potential Akt <extra_id_0> targets <extra_id_2> Binding <extra_id_1> , immunoblot analysis for p-mTOR was performed .", "To identify other potential <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> targets , immunoblot analysis for p-mTOR was performed ."]]}
{"trigger": ["Activated <extra_id_0> p-mTOR <extra_id_2> Protein <extra_id_1> was not increased in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes or lymphoma cells , indicating that this pathway is not affected by <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> - induced <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> activation and does not contribute to lymphoma development ( Figure 6B ) .", "<extra_id_0> Activated <extra_id_2> Positive_regulation <extra_id_1> p-mTOR was not <extra_id_0> increased <extra_id_2> Positive_regulation <extra_id_1> in LMP1 transgenic lymphocytes or lymphoma cells , indicating that this pathway is not <extra_id_0> affected <extra_id_2> Regulation <extra_id_1> by LMP1 - <extra_id_0> induced <extra_id_2> Positive_regulation <extra_id_1> Akt <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> and does not contribute to lymphoma development ( Figure 6B ) ."], "relation": [["<extra_id_0> Activated <extra_id_2> Positive_regulation <extra_id_1> p-mTOR was not increased in LMP1 transgenic lymphocytes or lymphoma cells , indicating that this pathway is not affected by LMP1 - induced Akt activation and does not contribute to lymphoma development ( Figure 6B ) .", "Activated <extra_id_0> p-mTOR <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> was not increased in LMP1 transgenic lymphocytes or lymphoma cells , indicating that this pathway is not affected by LMP1 - induced Akt activation and does not contribute to lymphoma development ( Figure 6B ) ."], ["Activated p-mTOR was not <extra_id_0> increased <extra_id_2> Positive_regulation <extra_id_1> in LMP1 transgenic lymphocytes or lymphoma cells , indicating that this pathway is not affected by LMP1 - induced Akt activation and does not contribute to lymphoma development ( Figure 6B ) .", "<extra_id_0> Activated <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> p-mTOR was not increased in LMP1 transgenic lymphocytes or lymphoma cells , indicating that this pathway is not affected by LMP1 - induced Akt activation and does not contribute to lymphoma development ( Figure 6B ) ."], ["Activated p-mTOR was not increased in LMP1 transgenic lymphocytes or lymphoma cells , indicating that this pathway is not <extra_id_0> affected <extra_id_2> Regulation <extra_id_1> by LMP1 - induced Akt activation and does not contribute to lymphoma development ( Figure 6B ) .", "<extra_id_0> Activated <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> p-mTOR was not increased in LMP1 transgenic lymphocytes or lymphoma cells , indicating that this pathway is not affected by LMP1 - <extra_id_0> induced <extra_id_2> Positive_regulation <extra_id_2> Cause <extra_id_1> Akt activation and does not contribute to lymphoma development ( Figure 6B ) ."], ["Activated p-mTOR was not increased in LMP1 transgenic lymphocytes or lymphoma cells , indicating that this pathway is not affected by LMP1 - <extra_id_0> induced <extra_id_2> Positive_regulation <extra_id_1> Akt activation and does not contribute to lymphoma development ( Figure 6B ) .", "Activated p-mTOR was not increased in LMP1 transgenic lymphocytes or lymphoma cells , indicating that this pathway is not affected by <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_2> Cause <extra_id_1> - induced Akt <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> and does not contribute to lymphoma development ( Figure 6B ) ."], ["Activated p-mTOR was not increased in LMP1 transgenic lymphocytes or lymphoma cells , indicating that this pathway is not affected by LMP1 - induced Akt <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> and does not contribute to lymphoma development ( Figure 6B ) .", "Activated p-mTOR was not increased in LMP1 transgenic lymphocytes or lymphoma cells , indicating that this pathway is not affected by LMP1 - induced <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> activation and does not contribute to lymphoma development ( Figure 6B ) ."]]}
{"trigger": ["<extra_id_0> Akt <extra_id_2> Protein <extra_id_1> is also known to phosphorylate and induce the degradation of the pro-apoptotic Forkhead family of transcription factors , leading to cell cycle progression and survival in some human tumors [ 41 , 42 ] .", "Akt is also known to phosphorylate and induce the degradation of the pro-apoptotic Forkhead family of transcription factors , leading to cell cycle progression and survival in some human tumors [ 41 , 42 ] ."], "relation": []}
{"trigger": ["Immunoblot analysis of splenic B cells did not consistently detect p - <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> levels , a signal that targets <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> for degradation .", "Immunoblot analysis of splenic B cells did not consistently detect p - FoxO1 levels , a signal that <extra_id_0> targets <extra_id_2> Regulation <extra_id_1> FoxO1 for degradation ."], "relation": [["Immunoblot analysis of splenic B cells did not consistently detect p - FoxO1 levels , a signal that <extra_id_0> targets <extra_id_2> Regulation <extra_id_1> FoxO1 for degradation .", "Immunoblot analysis of splenic B cells did not consistently detect p - FoxO1 levels , a signal that targets <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> for degradation ."]]}
{"trigger": ["Hence , degradation of <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> was assessed by detection of total <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> levels .", "Hence , degradation of FoxO1 was assessed by detection of total FoxO1 levels ."], "relation": []}
{"trigger": ["Immunoblot analysis indicated that total <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> levels were greatly decreased in wild-type and <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphomas ( Figure 6B ) , suggesting that inhibition of the Forkhead signaling pathway is an important target of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> in lymphoma development .", "Immunoblot analysis indicated that total FoxO1 levels were greatly <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_1> in wild-type and LMP1 transgenic lymphomas ( Figure 6B ) , suggesting that inhibition of the Forkhead signaling pathway is an important target of Akt in lymphoma development ."], "relation": [["Immunoblot analysis indicated that total FoxO1 levels were greatly <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_1> in wild-type and LMP1 transgenic lymphomas ( Figure 6B ) , suggesting that inhibition of the Forkhead signaling pathway is an important target of Akt in lymphoma development .", "Immunoblot analysis indicated that total <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> levels were greatly decreased in wild-type and LMP1 transgenic lymphomas ( Figure 6B ) , suggesting that inhibition of the Forkhead signaling pathway is an important target of Akt in lymphoma development ."]]}
{"trigger": ["However , considering that <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> activation did not induce <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> degradation in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic B cells , <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> may not be the sole regulator of <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> , and it may be that progression to lymphoma requires modulation of multiple pathways .", "However , considering that Akt <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> did not <extra_id_0> induce <extra_id_2> Positive_regulation <extra_id_1> FoxO1 <extra_id_0> degradation <extra_id_2> Negative_regulation <extra_id_1> in LMP1 transgenic B cells , Akt may not be the sole <extra_id_0> regulator <extra_id_2> Regulation <extra_id_1> of FoxO1 , and it may be that progression to lymphoma requires modulation of multiple pathways ."], "relation": [["However , considering that Akt <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> did not induce FoxO1 degradation in LMP1 transgenic B cells , Akt may not be the sole regulator of FoxO1 , and it may be that progression to lymphoma requires modulation of multiple pathways .", "However , considering that <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> activation did not induce FoxO1 degradation in LMP1 transgenic B cells , Akt may not be the sole regulator of FoxO1 , and it may be that progression to lymphoma requires modulation of multiple pathways ."], ["However , considering that Akt activation did not <extra_id_0> induce <extra_id_2> Positive_regulation <extra_id_1> FoxO1 degradation in LMP1 transgenic B cells , Akt may not be the sole regulator of FoxO1 , and it may be that progression to lymphoma requires modulation of multiple pathways .", "However , considering that Akt <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Cause <extra_id_1> did not induce FoxO1 <extra_id_0> degradation <extra_id_2> Negative_regulation <extra_id_2> Theme <extra_id_1> in LMP1 transgenic B cells , Akt may not be the sole regulator of FoxO1 , and it may be that progression to lymphoma requires modulation of multiple pathways ."], ["However , considering that Akt activation did not induce FoxO1 <extra_id_0> degradation <extra_id_2> Negative_regulation <extra_id_1> in LMP1 transgenic B cells , Akt may not be the sole regulator of FoxO1 , and it may be that progression to lymphoma requires modulation of multiple pathways .", "However , considering that Akt activation did not induce <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> degradation in LMP1 transgenic B cells , Akt may not be the sole regulator of FoxO1 , and it may be that progression to lymphoma requires modulation of multiple pathways ."], ["However , considering that Akt activation did not induce FoxO1 degradation in LMP1 transgenic B cells , Akt may not be the sole <extra_id_0> regulator <extra_id_2> Regulation <extra_id_1> of FoxO1 , and it may be that progression to lymphoma requires modulation of multiple pathways .", "However , considering that Akt activation did not induce FoxO1 degradation in LMP1 transgenic B cells , <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Cause <extra_id_1> may not be the sole regulator of <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , and it may be that progression to lymphoma requires modulation of multiple pathways ."]]}
{"trigger": ["The Forkhead family of transcription factors is known to induce the expression of the Cdk inhibitor <extra_id_0> p27 <extra_id_2> Protein <extra_id_1> [ 43 , 44 ] .", "The Forkhead family of transcription factors is known to induce the <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> of the Cdk inhibitor p27 [ 43 , 44 ] ."], "relation": [["The Forkhead family of transcription factors is known to induce the <extra_id_0> expression <extra_id_2> Gene_expression <extra_id_1> of the Cdk inhibitor p27 [ 43 , 44 ] .", "The Forkhead family of transcription factors is known to induce the expression of the Cdk inhibitor <extra_id_0> p27 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> [ 43 , 44 ] ."]]}
{"trigger": ["<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> - transformed rodent fibroblasts have decreased expression of <extra_id_0> p27 <extra_id_2> Protein <extra_id_1> , upregulation of <extra_id_0> Cdk2 <extra_id_2> Protein <extra_id_1> , and subsequent phosphorylation and inactivation of the tumor suppressor gene <extra_id_0> Rb <extra_id_2> Protein <extra_id_1> [ 45 ] .", "LMP1 - transformed rodent fibroblasts have decreased expression of p27 , upregulation of Cdk2 , and subsequent phosphorylation and inactivation of the tumor suppressor gene Rb [ 45 ] ."], "relation": []}
{"trigger": ["To investigate whether <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> affected cell cycle regulation through the <extra_id_0> Rb <extra_id_2> Protein <extra_id_1> pathway in B cells , immunoblot analyses for <extra_id_0> pRb <extra_id_2> Protein <extra_id_1> , <extra_id_0> Cdk2 <extra_id_2> Protein <extra_id_1> , and <extra_id_0> p27 <extra_id_2> Protein <extra_id_1> were performed on splenic <extra_id_0> CD19 <extra_id_2> Protein <extra_id_1> + MACS-purified B cells .", "To investigate whether LMP1 affected cell cycle regulation through the Rb pathway in B cells , immunoblot analyses for pRb , Cdk2 , and p27 were performed on splenic CD19 + MACS-purified B cells ."], "relation": []}
{"trigger": ["<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic B cells had enhanced levels of <extra_id_0> pRb <extra_id_2> Protein <extra_id_1> with concomitant stabilization of total <extra_id_0> Rb <extra_id_2> Protein <extra_id_1> levels and <extra_id_0> Cdk2 <extra_id_2> Protein <extra_id_1> compared to wild-type B lymphocytes ( Figure 6C ) .", "LMP1 transgenic B cells had <extra_id_0> enhanced <extra_id_2> Positive_regulation <extra_id_1> levels of pRb with concomitant stabilization of total Rb levels and Cdk2 compared to wild-type B lymphocytes ( Figure 6C ) ."], "relation": [["LMP1 transgenic B cells had <extra_id_0> enhanced <extra_id_2> Positive_regulation <extra_id_1> levels of pRb with concomitant stabilization of total Rb levels and Cdk2 compared to wild-type B lymphocytes ( Figure 6C ) .", "LMP1 transgenic B cells had enhanced levels of <extra_id_0> pRb <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> with concomitant stabilization of total Rb levels and <extra_id_0> Cdk2 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> compared to wild-type B lymphocytes ( Figure 6C ) ."]]}
{"trigger": ["Progression to lymphoma in both wild-type and <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphoma cells led to increased levels of <extra_id_0> Rb <extra_id_2> Protein <extra_id_1> , correspondingly high levels of <extra_id_0> Cdk2 <extra_id_2> Protein <extra_id_1> , and decreased levels of <extra_id_0> p27 <extra_id_2> Protein <extra_id_1> ( Figure 6C ) .", "Progression to lymphoma in both wild-type and LMP1 transgenic lymphoma cells <extra_id_0> led <extra_id_2> Positive_regulation <extra_id_1> to <extra_id_0> increased <extra_id_2> Positive_regulation <extra_id_1> levels of Rb , correspondingly <extra_id_0> high levels <extra_id_2> Positive_regulation <extra_id_1> of Cdk2 , and <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_1> levels of p27 ( Figure 6C ) ."], "relation": [["Progression to lymphoma in both wild-type and LMP1 transgenic lymphoma cells <extra_id_0> led <extra_id_2> Positive_regulation <extra_id_1> to increased levels of Rb , correspondingly high levels of Cdk2 , and decreased levels of p27 ( Figure 6C ) .", "Progression to lymphoma in both wild-type and LMP1 transgenic lymphoma cells led to <extra_id_0> increased <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> levels of Rb , correspondingly high levels of Cdk2 , and decreased levels of p27 ( Figure 6C ) ."], ["Progression to lymphoma in both wild-type and LMP1 transgenic lymphoma cells led to <extra_id_0> increased <extra_id_2> Positive_regulation <extra_id_1> levels of Rb , correspondingly high levels of Cdk2 , and decreased levels of p27 ( Figure 6C ) .", "Progression to lymphoma in both wild-type and LMP1 transgenic lymphoma cells led to increased levels of <extra_id_0> Rb <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , correspondingly high levels of Cdk2 , and decreased levels of p27 ( Figure 6C ) ."], ["Progression to lymphoma in both wild-type and LMP1 transgenic lymphoma cells led to increased levels of Rb , correspondingly <extra_id_0> high levels <extra_id_2> Positive_regulation <extra_id_1> of Cdk2 , and decreased levels of p27 ( Figure 6C ) .", "Progression to lymphoma in both wild-type and LMP1 transgenic lymphoma cells led to increased levels of Rb , correspondingly high levels of <extra_id_0> Cdk2 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , and decreased levels of p27 ( Figure 6C ) ."], ["Progression to lymphoma in both wild-type and LMP1 transgenic lymphoma cells led to increased levels of Rb , correspondingly high levels of Cdk2 , and <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_1> levels of p27 ( Figure 6C ) .", "Progression to lymphoma in both wild-type and LMP1 transgenic lymphoma cells led to increased levels of Rb , correspondingly high levels of Cdk2 , and decreased levels of <extra_id_0> p27 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> ( Figure 6C ) ."]]}
{"trigger": ["These data indicate that the <extra_id_0> Rb <extra_id_2> Protein <extra_id_1> pathway is deregulated in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and that lymphoma cells are distinguished by loss of <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> and decreased <extra_id_0> p27 <extra_id_2> Protein <extra_id_1> .", "These data indicate that the Rb pathway is deregulated in LMP1 transgenic lymphocytes and that lymphoma cells are distinguished by <extra_id_0> loss <extra_id_2> Negative_regulation <extra_id_1> of FoxO1 and <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_1> p27 ."], "relation": [["These data indicate that the Rb pathway is deregulated in LMP1 transgenic lymphocytes and that lymphoma cells are distinguished by <extra_id_0> loss <extra_id_2> Negative_regulation <extra_id_1> of FoxO1 and decreased p27 .", "These data indicate that the Rb pathway is deregulated in LMP1 transgenic lymphocytes and that lymphoma cells are distinguished by loss of <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and decreased p27 ."], ["These data indicate that the Rb pathway is deregulated in LMP1 transgenic lymphocytes and that lymphoma cells are distinguished by loss of FoxO1 and <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_1> p27 .", "These data indicate that the Rb pathway is deregulated in LMP1 transgenic lymphocytes and that lymphoma cells are distinguished by loss of FoxO1 and decreased <extra_id_0> p27 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> ."]]}
